Skip to content
PubMed This is a summary of 69 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 69 referenced papers

Top Authors

Angelo Valerio Marzano
University of Milan
Frédéric A. Caux
Université Sorbonne Paris Nord
Norito Ishii
Kurume University
Hazem A. Juratli
University of Basel
Enno Schmidt
University of Lübeck
P. Joly
Inserm
Catherine Prost‐Squarcioni
Université Sorbonne Paris Nord
Marzia Caproni
University of Florence

Top Institutions

Ranked by publications Top 10 institutions
02

University of Milan

Milan, Italy

10 papers
07

Jacksonville College

Jacksonville, United States

4 papers
08

University of Basel

Basel, Switzerland

3 papers
Contributors Hazem A. Juratli
09

Osaka Metropolitan University

Osaka, Japan

16 papers

References

References (69)
  1. 1

    Linear IgA bullous dermatosis: a retrospective study of 23 patients in Denmark.

    Lings K, Bygum A

    Acta dermato-venereologica 2015; (95(4)):466-71 doi:10.2340/00015555-1990.

    PMID: 25350667
  2. 2

    Dapsone in the treatment of pemphigus vulgaris: adverse effects and its importance as a corticosteroid sparing agent.

    Quaresma MV, Bernardes Filho F, Hezel J, et al.

    Anais brasileiros de dermatologia 2015; (90(3 Suppl 1)):51-4.

    PMID: 26312673
  3. 3

    Diaminodiphenyl Sulfone-Induced Hemolytic Anemia and Alopecia in a Case of Linear IgA Bullous Dermatosis.

    Akasaka E, Kayo SJ, Nakano H, et al.

    Case reports in dermatology 2015; (7(2)):183-6 doi:10.1159/000438506.

    PMID: 26351428
  4. 4

    Immune-mediated reactions to vancomycin: A systematic case review and analysis.

    Minhas JS, Wickner PG, Long AA, et al.

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2016; (116(6)):544-53.

    PMID: 27156746
  5. 5

    Vancomycin-induced linear IgA bullous dermatosis: associations.

    Gameiro A, Gouveia M, Tellechea O, Goncalo M

    Dermatology online journal 2016; (22(4)).

    PMID: 27617457
  6. 6

    Combined Use of Rituximab and Intravenous Immunoglobulin for Severe Autoimmune Cicatricial Conjunctivitis-An Interventional Case Series.

    Steger B, Madhusudan S, Kaye SB, et al.

    Cornea 2016; (35(12)):1611-1614 doi:10.1097/ICO.0000000000001024.

    PMID: 27661067
  7. 7

    A clinical and serological study of linear IgA bullous dermatosis without linear immunoglobulin deposition other than IgA at the basement membrane zone using direct immunofluorescence.

    Ohata C, Ishii N, Koga H, Nakama T

    The British journal of dermatology 2017; (177(1)):152-157 doi:10.1111/bjd.15232.

    PMID: 27943257
  8. 8

    Idiopathic linear IgA bullous dermatosis: prognostic factors based on a case series of 72 adults.

    Gottlieb J, Ingen-Housz-Oro S, Alexandre M, et al.

    The British journal of dermatology 2017; (177(1)):212-222 doi:10.1111/bjd.15244.

    PMID: 27995619
  9. 9

    The "Pearls" of Multidisciplinary Team: Conquering the Uncommon Rosette Rash.

    Verma N, Pickles C, Khan MA

    Case reports in pediatrics 2016; (2016()):5328603 doi:10.1155/2016/5328603.

    PMID: 28070436
  10. 10

    Linear immunoglobulin A dermatosis mimicking toxic epidermal necrolysis: a case report of etanercept treatment.

    Prieto-Barrios M, Velasco-Tamariz V, Tous-Romero F, et al.

    The British journal of dermatology 2018; (178(3)):786-789 doi:10.1111/bjd.15400.

    PMID: 28222222
  11. 11

    Linear IgA bullous dermatosis mimicking oral lichen planus.

    Shah S, Mohr B, Parekh P

    Proceedings (Baylor University. Medical Center) 2017; (30(3)):360-361 doi:10.1080/08998280.2017.11929649.

    PMID: 28670088
  12. 12

    Sublamina densa-type linear IgA bullous dermatosis with IgA autoantibodies specific for type VII collagen: a case report and clinicopathological review of 32 cases.

    Utsunomiya N, Chino T, Oyama N, et al.

    Dermatology online journal 2017; (23(11)).

    PMID: 29447635
  13. 13

    Linear IgA bullous dermatosis associated with ulcerative proctitis: treatment challenge.

    Yetto T, Burns C

    Dermatology online journal 2018; (24(7)).

    PMID: 30261573
  14. 14

    Drug-induced linear immunoglobulin A bullous dermatosis: A French retrospective pharmacovigilance study of 69 cases.

    Garel B, Ingen-Housz-Oro S, Afriat D, et al.

    British journal of clinical pharmacology 2019; (85(3)):570-579 doi:10.1111/bcp.13827.

    PMID: 30511379
  15. 15

    [Linear IgA bullous dermatosis].

    Juratli HA, Sárdy M

    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 2019; (70(4)):254-259 doi:10.1007/s00105-019-4377-9.

    PMID: 30874843
  16. 16

    An array of unusual clinical features in a woman with amlodipine-induced linear immunoglobulin A disease.

    Ailawadi P, Narang I, Garg VK

    International journal of women's dermatology 2019; (5(2)):92-95 doi:10.1016/j.ijwd.2018.11.004.

    PMID: 30997380
  17. 17

    Linear IgA bullous dermatosis in adults and children: a clinical and immunopathological study of 38 patients.

    Genovese G, Venegoni L, Fanoni D, et al.

    Orphanet journal of rare diseases 2019; (14(1)):115 doi:10.1186/s13023-019-1089-2.

    PMID: 31126328
  18. 18

    Consensus on the treatment of autoimmune bullous dermatoses: dermatitis herpetiformis and linear IgA bullous dermatosis - Brazilian Society of Dermatology.

    Vale ECSD, Dimatos OC, Porro AM, Santi CG

    Anais brasileiros de dermatologia 2019; (94(2 Suppl 1)):48-55 doi:10.1590/abd1806-4841.2019940208.

    PMID: 31166403
  19. 19

    Topical imiquimod-induced linear IgA bullous dermatosis.

    Tadiotto Cicogna G, Ferranti M, Vaccari D, Alaibac M

    BMJ case reports 2019; (12(7)) doi:10.1136/bcr-2019-230037.

    PMID: 31326906
  20. 20

    Linear IgA Disease: A Rare Complication of Vancomycin.

    Saleem M, Iftikhar H

    Cureus 2019; (11(6)):e4848 doi:10.7759/cureus.4848.

    PMID: 31410331
  21. 21

    Linear IgA dermatosis in association with angioimmunoblastic T-cell lymphoma infiltrating the skin: A case report with literature review.

    Colmant C, Camboni A, Dekeuleneer V, et al.

    Journal of cutaneous pathology 2020; (47(3)):251-256 doi:10.1111/cup.13576.

    PMID: 31482600
  22. 22

    Dapsone-induced hepatic complications: it's time to think beyond methemoglobinemia.

    Ezhilarasan D

    Drug and chemical toxicology 2021; (44(3)):330-333 doi:10.1080/01480545.2019.1679829.

    PMID: 31631707
  23. 23

    Successful treatment of a case of idiopathic linear IgA bullous dermatosis with oral sulfasalazine.

    Yang Z, Liu ZH, Sun CQ, Shen H

    Dermatologic therapy 2020; (33(2)):e13210 doi:10.1111/dth.13210.

    PMID: 31895494
  24. 24

    Autoantibody Profile of a Cohort of 54 Italian Patients with Linear IgA Bullous Dermatosis: LAD-1 Denoted as a Major Auto-antigen of the Lamina Lucida Subtype.

    Cozzani E, Di Zenzo G, Gasparini G, et al.

    Acta dermato-venereologica 2020; (100(4)):adv00070 doi:10.2340/00015555-3415.

    PMID: 32011724
  25. 25

    A Case of Dapsone-induced Mild Methemoglobinemia with Dyspnea and Cyanosis.

    Hayama Y, Imanishi H, Yoshimoto N, et al.

    Acta dermatovenerologica Croatica : ADC 2020; (28(4)):249-250.

    PMID: 33835002
  26. 26

    Idiopathic linear IgA bullous dermatosis treated with prednisone.

    Garces CC, Salam MF, Nohomovich B, Varghese MT

    BMJ case reports 2021; (14(5)) doi:10.1136/bcr-2021-242237.

    PMID: 33980564
  27. 27

    Updates in the Diagnosis and Management of Linear IgA Disease: A Systematic Review.

    Shin L, Gardner JT, Dao H

    Medicina (Kaunas, Lithuania) 2021; (57(8)) doi:10.3390/medicina57080818.

    PMID: 34441024
  28. 28

    Clinical features of chronic bullous dermatosis of childhood.

    Wilson A, Murrell DF

    Clinical and experimental dermatology 2022; (47(5)):873-881 doi:10.1111/ced.15059.

    PMID: 34919291
  29. 29

    Anti-FcαRI Monoclonal Antibodies Resolve IgA Autoantibody-Mediated Disease.

    Bos A, Aleyd E, van der Steen LPE, et al.

    Frontiers in immunology 2022; (13()):732977 doi:10.3389/fimmu.2022.732977.

    PMID: 35371001
  30. 30

    Linear Immunoglobulin A (IgA) Bullous Dermatosis Mimicking Stevens-Johnson Syndrome.

    Park JS, Hamilton CD, Patel S, et al.

    Cureus 2022; (14(10)):e30309 doi:10.7759/cureus.30309.

    PMID: 36381872
  31. 31

    A String of Pearls: Linear Immunoglobulin A (IgA) Bullous Dermatosis in the Setting of Imipramine Use and Newly Diagnosed Ulcerative Colitis.

    Davis S, Altattan M, Abugharbyeh A, et al.

    Cureus 2023; (15(1)):e33448 doi:10.7759/cureus.33448.

    PMID: 36751220
  32. 32

    Epidermolysis Bullosa Acquisita-Current and Emerging Treatments.

    Tešanović Perković D, Bukvić Mokos Z, Marinović B

    Journal of clinical medicine 2023; (12(3)) doi:10.3390/jcm12031139.

    PMID: 36769788
  33. 33

    Linear IgA bullous dermatosis of childhood.

    Nasri J, Jungo P, Blickenstorfer M, et al.

    Dermatology online journal 2022; (28(5)) doi:10.5070/D328559270.

    PMID: 36809139
  34. 34

    Linear IgA bullous dermatosis in an acute myeloid leukemia patient: a rare case report.

    Kianindra DV, Rosa A, Pebriany D, et al.

    Acta dermatovenerologica Alpina, Pannonica, et Adriatica 2023; (32(1)):19-22.

    PMID: 36945763
  35. 35

    Localized Linear IgA Bullous Dermatosis and a Recurrent Cicatricial Ectropion of the Eyelid: A Case Report of a Sixteen-Year Follow-up.

    Drnovšek-Olup B, Matović K

    Indian journal of dermatology 2022; (67(6)):835 doi:10.4103/ijd.ijd_909_20.

    PMID: 36998840
  36. 36

    Management Options for Linear Immunoglobulin A (IgA) Bullous Dermatosis: A Literature Review.

    Khan M, Park L, Skopit S

    Cureus 2023; (15(3)):e36481 doi:10.7759/cureus.36481.

    PMID: 37090290
  37. 37

    Hemolysis and Metabolic Lesion of G6PD Deficient RBCs in Response to Dapsone Hydroxylamine in a Humanized Mouse Model.

    Dziewulska KH, Reisz JA, Hay AM, et al.

    The Journal of pharmacology and experimental therapeutics 2023; (386(3)):323-330 doi:10.1124/jpet.123.001634.

    PMID: 37348965
  38. 38

    Vancomycin-induced bullous dermatosis: a rare case report.

    Sakkal N, Jazmati A, Alosman MA, et al.

    Annals of medicine and surgery (2012) 2023; (85(6)):3022-3025 doi:10.1097/MS9.0000000000000752.

    PMID: 37363561
  39. 39

    Anti-NC16A IgA from Patients with Linear IgA Bullous Dermatosis Induce Neutrophil-Dependent Subepidermal Blistering in Mice.

    Jing K, Jordan TJM, Li N, et al.

    The Journal of investigative dermatology 2024; (144(1)):24-32.e1 doi:10.1016/j.jid.2023.05.027.

    PMID: 37437774
  40. 40

    Adult-onset linear IgA bullous dermatosis: a retrospective single-center cohort study of 81 patients and literature review.

    Wang KL, Lehman JS, Todd A, Davis DMR

    International journal of dermatology 2024; (63(7)):936-941 doi:10.1111/ijd.17041.

    PMID: 38251749
  41. 41

    Development of a multivariate predictive model for dapsone adverse drug events in people with leprosy under standard WHO multidrug therapy.

    de Araujo ACGDS, Hacker MAV, Pinheiro RO, et al.

    PLoS neglected tropical diseases 2024; (18(1)):e0011901 doi:10.1371/journal.pntd.0011901.

    PMID: 38271456
  42. 42

    Linear IgA bullous dermatosis of childhood: Retrospective single-center cohort.

    Wang KL, Lehman JS, Davis DMR

    Pediatric dermatology 2024; (41(3)):461-464 doi:10.1111/pde.15567.

    PMID: 38378007
  43. 43

    S2k guidelines on diagnosis and treatment of linear IgA dermatosis initiated by the European Academy of Dermatology and Venereology.

    Caux F, Patsatsi A, Karakioulaki M, et al.

    Journal of the European Academy of Dermatology and Venereology : JEADV 2024; (38(6)):1006-1023 doi:10.1111/jdv.19880.

    PMID: 38421060
  44. 44

    Linear IgA bullous dermatosis associated with immunotherapy.

    Momin B, Nguyen TF, Glade D, Messer A

    Dermatology online journal 2023; (29(6)) doi:10.5070/D329662995.

    PMID: 38478666
  45. 45

    Airway management of a patient with linear immunoglobulin A bullous dermatosis: A case report.

    Nin OC, Hutnik R, Chheda NN, Hutchinson D

    World journal of clinical cases 2024; (12(13)):2263-2268 doi:10.12998/wjcc.v12.i13.2263.

    PMID: 38808340
  46. 46

    State-of-the-art diagnosis of autoimmune blistering diseases.

    van Beek N, Holtsche MM, Atefi I, et al.

    Frontiers in immunology 2024; (15()):1363032 doi:10.3389/fimmu.2024.1363032.

    PMID: 38903493
  47. 47

    Case report: Dupilumab: a promising treatment option for adult linear IgA bullous dermatosis with severe pruritus.

    Wang L, Peng J, Chen J

    Frontiers in immunology 2024; (15()):1409556 doi:10.3389/fimmu.2024.1409556.

    PMID: 39161758
  48. 48

    Histopathologic Overlap Between Bullous Lupus Erythematosus and Linear IgA Bullous Dermatosis: A Comparative Study.

    Murugesu L, Tirumalae R

    The American Journal of dermatopathology 2024; (46(11)):739-745 doi:10.1097/DAD.0000000000002825.

    PMID: 39288759
  49. 49

    A Comparative Study of Direct Immunofluorescence Patterns in Linear IgA Bullous Dermatosis Versus Dermatitis Herpetiformis.

    Sagut P, Lyles E, Vroman J, et al.

    The American Journal of dermatopathology 2024; (47(7)):505-511 doi:10.1097/DAD.0000000000002864.

    PMID: 39570799
  50. 50

    Linear IgA bullous dermatosis: 32 years of experience.

    Atci T, Pehlivan Ulutas G, Güreler Sirkeci E, Küçükoğlu R

    Anais brasileiros de dermatologia 2025; (100(2)):277-282 doi:10.1016/j.abd.2024.03.015.

    PMID: 39665877
  51. 51

    Improvement of immunological tests for detecting autoantibodies in patients with lamina lucida-type linear IgA bullous dermatosis.

    Tsutsumi M, Koga H, Teye K, et al.

    Journal of dermatological science 2025; (117(1)):2-7 doi:10.1016/j.jdermsci.2024.12.001.

    PMID: 39732612
  52. 52

    Linear IgA bullous dermatosis-a fifty year experience of Warsaw Center of bullous diseases.

    Kowalewski C, Wozniak K

    Frontiers in immunology 2024; (15()):1478318 doi:10.3389/fimmu.2024.1478318.

    PMID: 39877369
  53. 53

    Linear IgA bullous dermatosis secondary to drugs: a real-world pharmacovigilance study of the FDA adverse event reporting system.

    Yang Y, Xie H, Liu S, et al.

    Frontiers in medicine 2025; (12()):1521697 doi:10.3389/fmed.2025.1521697.

    PMID: 39917062
  54. 54

    Clinical characteristics and treatment outcomes of linear IgA bullous dermatosis.

    Mar K, Landells F, Khalid B, et al.

    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2025; (23(5)):576-585 doi:10.1111/ddg.15644.

    PMID: 40018881
  55. 55

    Amoxicillin-induced linear IgA bullous dermatosis mimicking erythema multiforme: a case report.

    Silagy M, Carvalho P, Tedbirt B, et al.

    Skin health and disease 2025; (5(1)):75-78 doi:10.1093/skinhd/vzae024.

    PMID: 40125011
  56. 56

    A Narrative Review of Pemphigoid Diseases: Bridging Associations, Comorbidities, and Management.

    Myers EL, Culton DA

    Dermatology and therapy 2025; (15(7)):1755-1770 doi:10.1007/s13555-025-01444-9.

    PMID: 40411679
  57. 57

    Methaemoglobinaemia as an Alternative Diagnosis for Shortness of Breath: A Case Report.

    Thiri T, San SS, Lwin ZT

    Cureus 2025; (17(5)):e83525 doi:10.7759/cureus.83525.

    PMID: 40470439
  58. 58

    Childhood Linear IgA Dermatosis Successfully Treated with the Combination of Dapsone and Sulfasalazine.

    Kim AS, Sundnes O

    Case reports in dermatology 2025; (17(1)):185-190 doi:10.1159/000546155.

    PMID: 40475121
  59. 59

    Vancomycin-Induced Linear IgA Bullous Dermatosis Mimicking Stevens-Johnson Syndrome Associated With Anticancer Therapy.

    Haymete MA, Casado GL, Rizzo MT, et al.

    The American Journal of dermatopathology 2025; (47(10)):798-802 doi:10.1097/DAD.0000000000003023.

    PMID: 40568795
  60. 60

    Molecular Mechanisms of Drug-Induced Hemolysis in G6PD Deficiency: Mechanistic Insights.

    Paika S, Machini M, Parmar MS

    Oxidative medicine and cellular longevity 2025; (2025()):7041213 doi:10.1155/omcl/7041213.

    PMID: 40799291
  61. 61

    Drug-Induced Linear IgA Bullous Dermatosis Emerging After Vancomycin Discontinuation in Renal Impairment: Management Amid Serious Infection.

    Peake KE, Chow EY

    Cureus 2025; (17(8)):e91255 doi:10.7759/cureus.91255.

    PMID: 41030698
  62. 62

    A Rare Type of Bullous Disorder in a Child. Can It Be Chronic Bullous Disease of Childhood?

    Yadav R, Poudel I, Poudyal Y, Chaudhary N

    Clinical case reports 2026; (14(1)):e71746 doi:10.1002/ccr3.71746.

    PMID: 41473884
  63. 63

    Linear IgA Bullous Dermatosis in an Elderly Patient Following Meloxicam and Candesartan Use: A Case Report.

    Albyali S, Alhedaithi N, Alqahtani R, et al.

    Cureus 2025; (17(12)):e99054 doi:10.7759/cureus.99054.

    PMID: 41527635
  64. 64

    European S2k guidelines on management of autoimmune blistering diseases in children and adolescents.

    Nanda A, Tedbirt B, Bodemer C, et al.

    Journal of the European Academy of Dermatology and Venereology : JEADV 2026; (40(7)):1137-1161 doi:10.1111/jdv.70308.

    PMID: 41678328
  65. 65

    A Rapidly Progressive Bullous Eruption in a Toddler.

    Khalid A, Ghouri S, Proano JS

    Cureus 2026; (18(1)):e101419 doi:10.7759/cureus.101419.

    PMID: 41695009
  66. 66

    A Case of Linear IgA Bullous Dermatosis of Childhood With Ocular Involvement: A Diagnostic Challenge.

    Haidar H, Amos-Oluwole O, Loomba A, et al.

    Cornea 2026; (45(8)):1051-1055 doi:10.1097/ICO.0000000000004087.

    PMID: 42241023
  67. 67

    Management of Recurrent Linear IgA Dermatosis of Childhood in the Absence of Histopathology and Immunofluorescence: A Case Report from a Low-Resource Setting in South-Western Uganda.

    Olwit G, Nek AJ, Chris-Uchendu HC, et al.

    Clinical, cosmetic and investigational dermatology 2026; (19()):619152 doi:10.2147/CCID.S619152.

    PMID: 42299444
  68. 68

    Clinical Indicators Suggesting Dapsone-Induced Methemoglobinemia in Dermatology Outpatients: A Pilot Retrospective Cohort Study.

    Mathews J, Thomas A, Lekshmi S P, et al.

    Cureus 2026; (18(6)):e111188 doi:10.7759/cureus.111188.

    PMID: 42333280
  69. 69

    Clinical characteristics, treatment, and outcomes of vancomycin-induced linear IgA bullous dermatosis.

    Wu Z, Sun W, Wang C

    Pharmacology 2026; 1-13 doi:10.1159/000552120.

    PMID: 42599841